Portal de Periódicos da CAPES

Elevated plasma levels of endothelin‐1 in systemic sclerosis

1991; Wiley; Volume: 34; Issue: 2 Linguagem: Inglês

10.1002/art.1780340220

1529-0131

Kazuhide Yamane, Heihachiro Kashiwagi, Nobuhiro Suzuki, Takashi Miyauchi, Masashi Yanagisawa, Katsutoshi Goto, Τοmoh Masaki,

Eosinophilic Disorders and Syndromes

Arthritis & RheumatismVolume 34, Issue 2 p. 243-244 LetterFree to Read Elevated plasma levels of endothelin-1 in systemic sclerosis Kazuhide Yamane MD, PhD, Kazuhide Yamane MD, PhD University of Tsukuba and Tsukuba Research Laboratories Takeda Chemical Industries Tsukuba, Ibaraki, JapanSearch for more papers by this authorHeihachiro Kashiwagi MD, PhD, Heihachiro Kashiwagi MD, PhD University of Tsukuba and Tsukuba Research Laboratories Takeda Chemical Industries Tsukuba, Ibaraki, JapanSearch for more papers by this authorNobuhiro Suzuki PhD, Nobuhiro Suzuki PhD University of Tsukuba and Tsukuba Research Laboratories Takeda Chemical Industries Tsukuba, Ibaraki, JapanSearch for more papers by this authorTakashi Miyauchi MD, PhD, Takashi Miyauchi MD, PhD University of Tsukuba and Tsukuba Research Laboratories Takeda Chemical Industries Tsukuba, Ibaraki, JapanSearch for more papers by this authorMasashi Yanagisawa MD, PhD, Masashi Yanagisawa MD, PhD University of Tsukuba and Tsukuba Research Laboratories Takeda Chemical Industries Tsukuba, Ibaraki, JapanSearch for more papers by this authorKatsutoshi Goto PhD, Katsutoshi Goto PhD University of Tsukuba and Tsukuba Research Laboratories Takeda Chemical Industries Tsukuba, Ibaraki, JapanSearch for more papers by this authorTomoh Masaki MD, PhD, Tomoh Masaki MD, PhD University of Tsukuba and Tsukuba Research Laboratories Takeda Chemical Industries Tsukuba, Ibaraki, JapanSearch for more papers by this author Kazuhide Yamane MD, PhD, Kazuhide Yamane MD, PhD University of Tsukuba and Tsukuba Research Laboratories Takeda Chemical Industries Tsukuba, Ibaraki, JapanSearch for more papers by this authorHeihachiro Kashiwagi MD, PhD, Heihachiro Kashiwagi MD, PhD University of Tsukuba and Tsukuba Research Laboratories Takeda Chemical Industries Tsukuba, Ibaraki, JapanSearch for more papers by this authorNobuhiro Suzuki PhD, Nobuhiro Suzuki PhD University of Tsukuba and Tsukuba Research Laboratories Takeda Chemical Industries Tsukuba, Ibaraki, JapanSearch for more papers by this authorTakashi Miyauchi MD, PhD, Takashi Miyauchi MD, PhD University of Tsukuba and Tsukuba Research Laboratories Takeda Chemical Industries Tsukuba, Ibaraki, JapanSearch for more papers by this authorMasashi Yanagisawa MD, PhD, Masashi Yanagisawa MD, PhD University of Tsukuba and Tsukuba Research Laboratories Takeda Chemical Industries Tsukuba, Ibaraki, JapanSearch for more papers by this authorKatsutoshi Goto PhD, Katsutoshi Goto PhD University of Tsukuba and Tsukuba Research Laboratories Takeda Chemical Industries Tsukuba, Ibaraki, JapanSearch for more papers by this authorTomoh Masaki MD, PhD, Tomoh Masaki MD, PhD University of Tsukuba and Tsukuba Research Laboratories Takeda Chemical Industries Tsukuba, Ibaraki, JapanSearch for more papers by this author First published: February 1991 https://doi.org/10.1002/art.1780340220Citations: 64AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1 LeRoy EC: Pathogenesis of scleroderma (systemic sclerosis). J Invest Dermatol 79 (suppl 1): 87S–89S, 1982 10.1111/1523-1747.ep12545854 PubMedWeb of Science®Google Scholar 2 Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Goto K, Yazaki K, Masaki T: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 32: 411–415, 1988 10.1038/332411a0 CASGoogle Scholar 3 Yanagisawa M, Masaki T: Endothelin, a novel endothelium-derived peptide: pharmacological activities, regulation and possible roles in cardiovascular control. Biochem Phrmacol 38: 1877–1883, 1989 10.1016/0006-2952(89)90484-X CASPubMedWeb of Science®Google Scholar 4 Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23: 581–590, 1980 10.1002/art.1780230510 PubMedGoogle Scholar 5 Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25: 1271–1277, 1982 10.1002/art.1780251101 CASPubMedGoogle Scholar 6 Suzuki N, Matsumoto H, Kitada C, Masaki T, Fujino M: A sensitive sandwich-enzyme immunoassay for human endothelin. J Immunol Methods 118: 245–250, 1989 10.1016/0022-1759(89)90012-4 CASPubMedWeb of Science®Google Scholar 7 Kahaleh MB: "Endothelin"—an endothelial-dependent vasoconstrictor in scleroderma. Arthritis Rheum 32 (suppl 4): S76, 1989 Google Scholar 8 Cernacek P, Stewart DJ: Immunoreactive endothelin in human plasma: marked elevations in patients in cardiogenic shock. Biochem Biophys Res Comun 161: 562–567, 1989 10.1016/0006-291X(89)92636-3 CASPubMedWeb of Science®Google Scholar 9 Furst DE, David JA, Clements PJ, Chopra SL, Theofilopoulos AN, Chia D: Abnormalities of pulmonary vascular dynamics and inflammation in early progressive systemic sclerosis. Arthritis Rheum 24: 1403–1408, 1981 10.1002/art.1780241111 CASPubMedWeb of Science®Google Scholar Citing Literature Volume34, Issue2February 1991Pages 243-244 ReferencesRelatedInformation